Clinical trial · Observational
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
NCT06762925CI-TRIAL-00084479not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to validate the accuracy and clinical value of METTL3 as a biomarker for predicting immune therapy response in patients with urinary tract tumors through observational studies.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Kidney Cancer | Malignant Kidney Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Bladder Cancer
- interventionNames
- Other: No Interventions
- label
- Prostate Cancer
- interventionNames
- Other: No Interventions
- label
- Kidney Cancer
- interventionNames
- Other: No Interventions
Primary outcomes (1)
- measure
- The expression levels of METTL3 and ANGPTL2
- timeFrame
- About a year and a half
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients diagnosed with urinary system tumors through pathological examination; 2. Meet specific clinical stages and surgical treatment standards; 3. Intraoperative tissue resection meets the sample testing standards; 4. The patient is willing to participate in the study and sign an informed consent form. Exclusion Criteria: 1. Not meeting the specific clinical stage and not receiving surgical treatment; 2. Abnormal mental behavior; 3. Intellectual disability; 4. Age under 18 years old or over 75 years old; 5. Low understanding and communication skills.
References
Publications (0)
Data not yet available
No reference posted for this study.